Introduction
Medical device registration in Indonesia is the structured regulatory and operational function through which a business determines whether a product is regulated as a medical device, identifies the applicable Indonesian risk class and secures the correct company-license and product-license architecture required for lawful commercialization.
In practical terms, Indonesia combines Ministry of Health oversight, Regalkes filing, IDAK company licensing, CDAKB distribution compliance, local license-holder requirements and product-level NIE issuance in one integrated market-entry framework.
The subject is commercially important because Indonesia is a large and heavily import-dependent medtech market, while mistakes around local holder choice, IDAK readiness, CDAKB status, Bahasa labeling, product grouping or authorization term can delay or block lawful market entry.
Home
└── Jurisdictions
└── Indonesia
└── Medical Device Registration Indonesia
Identity
- Object: Medical Device Registration
- Jurisdiction: Indonesia
- Object ID: ID.MDR.001
- Reference: MAR-ID-MDR-001-A
Core Framework
- Ministry of Health-centered device regulation
- Class A to D risk-based system
- IDAK and CDAKB are company-level prerequisites
- NIE is the product-level marketing authorization
Operating Logic
- Foreign manufacturers cannot hold the Indonesian registration directly
- An Indonesian legal entity must hold the license
- Technical dossiers follow ASEAN CSDT logic
- Regalkes is the core filing platform for market authorization
Executive Summary
Medical device registration in Indonesia is the professional regulatory and market-access function concerned with determining whether a product falls within the Indonesian medical-device framework, identifying its risk class and securing the correct company and product authorization route for lawful commercialization.
The route is two-layered. The Regalkes platform states that it is the online application built to facilitate licensing processes that issue medical-device product distribution permits, while Indonesia market-entry guidance explains that IDAK licenses the Indonesian company and NIE registers the individual medical device as the marketing authorization.
The pathway is therefore company-driven as well as product-driven. Indonesia registration guidance explains that a company must hold IDAK and CDAKB before applying for any NIE and that Regalkes checks IDAK and CDAKB status before accepting the dossier.
The local-holder issue is also decisive. Indonesia registration guidance explains that a foreign manufacturer cannot hold an Indonesian NIE directly and must register through its own Indonesian PT PMA or through a local holder, while the NIE is issued per specific product and trade name rather than to an entire product family automatically.
| Definition | The professional regulatory and market-access function concerned with securing the lawful Indonesian registration and market-entry position for medical devices through classification, local license-holder alignment, IDAK and CDAKB readiness, ASEAN-style dossier preparation and NIE issuance. |
| Object | Medical Device Registration |
| Object Type | Professional Regulatory and Market-Access Function |
| Classification | Medical Devices, Indonesia, Ministry of Health, Regalkes, IDAK, CDAKB, NIE, AKL, AKD, CSDT, Class A, Class B, Class C, Class D, Local License Holder |
| Jurisdiction | Indonesia |
Definition
Medical device registration in Indonesia refers to the structured process through which a business determines whether its product is regulated as a medical device, identifies the relevant Indonesian class and secures the appropriate company-license and product-license route before commercialization.
The object is broader than filing one online application. It covers product qualification, A to D classification, local license-holder structuring, IDAK company licensing, CDAKB readiness, CSDT dossier preparation, Regalkes submission, NIE issuance, labeling and lifecycle maintenance.
| Covered Matters | Product qualification, class determination, local holder structuring, IDAK and CDAKB readiness, CSDT dossier preparation, Regalkes filing, NIE issuance, labeling, import-position analysis and lifecycle maintenance. |
| Functional Boundary | The Registry Object covers how businesses achieve and maintain lawful Indonesian market access for medical devices. |
| Related but Not Primary | Hospital procurement, reimbursement, distributor contracting, patent strategy and broader healthcare commercialization are adjacent but not the primary object here. |
| Outside Scope | Pharmaceutical-only approvals, unrelated consumer-product regulation, general company formation and broad tax planning. |
Scope
The Indonesia medical device registration function applies to products regulated as medical devices and to the Indonesian legal entities responsible for holding the relevant authorizations for market placement.
The scope is both product-facing and structure-facing. Indonesia registration guidance explains that foreign manufacturers cannot hold the NIE directly, that an Indonesian legal entity must hold the registration and that the company’s IDAK and CDAKB status is checked before product review proceeds.
Editorial Note: In Indonesia, a registration review is incomplete if it looks only at the product and ignores who holds the license, whether that entity is IDAK and CDAKB ready and whether the authorization term and commercial control model are aligned.
Purpose
The purpose of medical device registration in Indonesia is to convert a product, local authorization structure and regulatory dossier into a lawful Ministry of Health market-entry position.
In business terms, the function exists to identify the correct class and holder route, align the Indonesian company licenses, prepare the dossier for Regalkes and reduce the risk of entering Indonesia on an unsupported regulatory assumption.
Primary Outcome
A coherent Indonesia medical device registration position means that the device has been qualified correctly, matched to the applicable Class A, B, C or D category and linked to the correct Indonesian legal entity and product-authorization route for lawful commercialization.
Depending on the product and origin, the outcome may be an NIE tied to an imported-device or domestically manufactured-device code pattern, while company-level readiness remains dependent on IDAK and CDAKB. Indonesia registration guidance explains that NIE is the marketing authorization for one specific device and that IDAK licenses the company rather than the product.
Request Contexts
Request contexts show the business situations in which Indonesia registration work is usually activated. Most begin before launch, but the function is also relevant in distributor change, license-holder strategy, renewal, dossier variation, halal positioning and portfolio expansion.
| Identity Pattern | Manufacturer planning Indonesia entry, foreign manufacturer evaluating PT PMA or local-holder options, regulatory lead reviewing Indonesian class rules, importer assessing IDAK obligations, investor validating Indonesian authorization architecture. |
| Business Event | First Indonesia launch, class uncertainty, local representative structuring, IDAK planning, CDAKB audit readiness, new NIE filing, renewal, distributor change or product-portfolio expansion. |
| Typical User | Manufacturers, local license holders, importers, distributors, regulatory affairs managers, legal advisers, investors and international medtech businesses. |
| Typical Scenario | A company needs to determine whether its product is Class A, B, C or D, who will hold the Indonesian registration, whether IDAK and CDAKB are in place and how the CSDT dossier should be filed through Regalkes. |
Typical Users
Different actors encounter Indonesia registration from different positions, but the common issue is the need for a defensible answer on class, local holder and company-license readiness.
| Foreign Manufacturer | Needs to determine Indonesian classification, local holder route and the company-license structure required for lawful market access. |
| Indonesian License Holder | Needs to hold the required company licenses and support product registration and post-market obligations. |
| Regulatory Affairs Lead | Needs to align class, CSDT dossier, labeling, LOA term and authorization route with Ministry expectations. |
| Distributor or Importer | Needs to understand how IDAK, CDAKB and NIE affect actual import and distribution rights. |
| Investor or Transaction Adviser | Needs to validate that the Indonesian regulatory architecture is real, current and commercially usable. |
Typical Scenarios
Practical scenarios show where Indonesia registration analysis becomes operationally important.
| Initial Qualification | The business must determine whether the product is regulated as a medical device in Indonesia. |
| Class Strategy | The company needs to determine whether the device falls into Class A, B, C or D, because that drives dossier depth and review complexity. |
| Holder Strategy | The manufacturer needs to decide whether the NIE will be held by its own PT PMA or by an independent or distributor-based local holder. |
| IDAK and CDAKB Readiness | The company must determine whether the local entity has the required distribution license and GDP certification to support filing. |
| CSDT Dossier Planning | The business needs to prepare the ASEAN dossier, ISO 13485 evidence, risk file, labeling and authorization materials. |
| Renewal or Transfer Risk | The company needs to assess whether commercial flexibility is constrained because the NIE sits with a distributor-specific holder. |
Jurisdiction Characteristics
Indonesia is a Ministry of Health-centered medical-device jurisdiction with a formal A to D class-based system and a strong distinction between company licensing and product licensing.
A distinctive practical feature is the split between IDAK and NIE. Indonesia registration guidance explains that IDAK is the company license that allows an Indonesian entity to import, store and distribute medical devices, while NIE is the product registration issued for one specific device.
| Operational Culture | Formal, portal-driven and strongly structured around local legal-entity control, company-license readiness and product-specific authorization. |
| Legal Framework Orientation | Ministry of Health-led authorization system built around Regalkes filing, IDAK, CDAKB and product-level distribution permits. |
| Commercial Context | Large import-reliant market where holder strategy, IDAK readiness and dossier execution materially affect speed to market. |
| Language Expectation | Bahasa Indonesia labeling and IFU alignment are recurring practical requirements in the filing package. |
Key Authorities
Indonesia medical device registration is centered on the Ministry of Health and its Regalkes platform. The Regalkes portal states that the online system facilitates the public licensing process that issues Izin Edar product permits for medical devices and related household-health products.
| Official Name | Ministry of Health of the Republic of Indonesia |
| Official English Name | Ministry of Health |
| Primary Role | National authority responsible for medical-device licensing and product-registration control in Indonesia. |
| Responsibilities | Administers Regalkes, issues product distribution permits, manages company-license architecture and oversees market-entry compliance for medical devices. |
| Typical Interaction | Direct where a business needs company-license planning, product-registration support, portal compliance, advertising linkage or lifecycle management. |
| Official Website | Regalkes Portal |
| Cross-Border Relevance | High, because foreign manufacturers depend on an Indonesian legal entity and local licensing architecture to commercialize devices. |
Applicable Legislation
The Indonesia framework combines Ministry of Health licensing controls, Regalkes portal administration and implementing rules aligned with ASEAN medical-device submission logic. Indonesia registration guidance explains that the dossier is filed through the Regalkes portal under Health Minister Regulation 62 of 2017 and follows the ASEAN Common Submission Dossier Template.
| Official Title | Health Minister Regulation 62 of 2017 and related Ministry licensing framework |
| Year | 2017 and subsequent implementation |
| Purpose | Provides the basis for online registration, product-authorization processing and dossier expectations for Indonesian medical-device market access. |
| Typical Application | Used to determine dossier route, platform use and product-registration expectations for imported and domestic medical devices. |
| Related Legislation | IDAK and CDAKB licensing rules, technical-product requirements and other Ministry implementing regulations. |
| Official Source | Regalkes Portal |
| Current Status | Active framework. |
Process Flow
Indonesia medical device registration normally works as a staged process from product qualification to commercialization. Indonesia registration guidance explains that the process starts with class determination, then local holder readiness through IDAK and CDAKB, followed by CSDT dossier compilation, Regalkes filing, Ministry review and NIE issuance.
| 1. Product Qualification | Determine whether the product is regulated as a medical device in Indonesia. |
| 2. Risk Classification | Identify the applicable Class A, B, C or D category. |
| 3. Holder Strategy | Identify the Indonesian legal entity that will hold the registration. |
| 4. Company-License Readiness | Ensure the holder has IDAK and CDAKB in place before product registration is submitted. |
| 5. Dossier Preparation | Prepare the ASEAN CSDT file, including ISO 13485, risk documentation, labels, IFU and authorization materials. |
| 6. Portal Filing | Submit the application through Regalkes under the holder’s licenses. |
| 7. Authority Review | Undergo Ministry review for safety, quality and completeness. |
| 8. NIE Issuance | Obtain the product-level marketing authorization for the specific device. |
| 9. Market Launch | Commercialize only after the relevant product and company licenses are complete. |
| 10. Maintenance and Renewal | Maintain the authorization, renew on time and manage changes in holder, portfolio or labeling. |
| Typical Outputs | Qualification memo, class rationale, holder strategy memo, IDAK and CDAKB evidence, CSDT dossier, Regalkes submission record, NIE and lifecycle file. |
Decision Tree
The decision tree helps simplify the main Indonesia threshold questions.
- Confirm whether the product is regulated as a medical device in Indonesia.
- Determine the risk class because Indonesia uses Class A, B, C and D categories.
- Identify which Indonesian legal entity will hold the registration.
- Confirm whether that entity already has IDAK and CDAKB.
- Prepare the ASEAN CSDT dossier, including Bahasa Indonesia labeling alignment.
- Submit through Regalkes under the licensed holder.
- Obtain the NIE for the specific product before commercialization.
- Review whether renewal, transfer or distributor-change risk should be addressed structurally before launch.
Timeline
The Indonesia timeline begins before launch and continues after commercialization. Indonesia registration guidance explains that the Letter of Authorization should run for at least five years so the NIE can keep its full term, and that the NIE runs for up to five years and is renewable.
| Concept Stage | The business defines the product, intended use and Indonesia market objective. |
| Qualification Stage | The product is assessed to determine whether it is a medical device under Indonesian rules. |
| Classification Stage | The risk class is mapped because it determines dossier depth and review complexity. |
| Structure Stage | The Indonesian holder and commercial architecture are formalized. |
| Company-License Stage | IDAK and CDAKB are secured for the holder before product filing. |
| Dossier Stage | The business prepares the CSDT dossier and authorization materials. |
| Submission Stage | The application is filed through Regalkes. |
| Launch Stage | The device is commercialized after NIE issuance and local distribution readiness are complete. |
| Maintenance Stage | The business manages renewal, labeling updates and holder-related changes. |
Required Documents
The exact document set depends on class and product type, but Indonesia medical device registration depends on a coherent documentary file that supports both the company-license route and the product-registration route.
| Document | Product Qualification and Classification Record |
| Purpose | Explains why the product is regulated as a medical device in Indonesia and what class applies. |
| Typical Situation | Prepared at the beginning of Indonesia registration strategy. |
| Document | Holder and Authorization File |
| Purpose | Documents the Indonesian legal entity, LOA structure and holder authority for the registration. |
| Typical Situation | Used whenever a foreign manufacturer plans Indonesia market entry. |
| Document | IDAK and CDAKB Evidence |
| Purpose | Provides proof that the holder has the company-level licenses required before filing an NIE application. |
| Typical Situation | Used before product filing begins. |
| Document | CSDT Product Dossier |
| Purpose | Provides the ASEAN technical file, including ISO 13485, risk file, description, labeling and supporting evidence. |
| Typical Situation | Used in Regalkes filing for new registration. |
| Document | Bahasa Labeling and IFU Package |
| Purpose | Provides labels and instructions aligned with Indonesian language expectations and submission data. |
| Typical Situation | Used in dossier preparation and launch readiness. |
Cross-Border Relevance
Cross-border relevance is high because foreign manufacturers cannot register directly in Indonesia and must operate through an Indonesian legal entity. Indonesia registration guidance explains that a foreign manufacturer cannot hold the Indonesian NIE directly and must register through its own PT PMA or a local holder.
The cross-border issue is therefore not simply whether the product has foreign approvals elsewhere. It is whether the manufacturer has mapped the Indonesian holder strategy, the IDAK and CDAKB status, the dossier route and the commercial control implications of where the NIE sits.
| Recognition | Foreign approvals can support dossier strategy, but Indonesian company-license and NIE requirements still control commercialization. |
| Foreign Companies | Foreign manufacturers generally need a PT PMA or a local authorized representative or holder to commercialize devices. |
| Language Considerations | Bahasa Indonesia labeling and IFU alignment remain recurring practical requirements. |
| International Rules | Cross-border businesses must treat local holder choice, company-license readiness and Regalkes filing as core workstreams. |
| Practical Considerations | Indonesia entry strategy should treat local-holder control, commercial flexibility and product registration as one integrated architecture. |
| Typical Risk | Assuming foreign approval alone guarantees Indonesian access without checking local holder, IDAK, CDAKB or NIE position. |
KemenkesRegalkesIDAKCDAKBNIECSDT
Operating Constraints & Risks
Operating constraints identify the recurring failure points in Indonesia medical device registration. Many arise when businesses underestimate how closely holder control, company licensing, dossier readiness and commercial flexibility are linked.
| Qualification Risk | The product is misread as a medical device or non-device under Indonesian rules. |
| Class Risk | The wrong class is assumed, leading to the wrong dossier depth or incomplete review strategy. |
| Holder Risk | The manufacturer chooses a license-holder structure that creates avoidable distributor lock-in or weak commercial control. |
| Company-License Risk | IDAK or CDAKB is missing or expires, preventing filing or freezing the practical use of the registration structure. |
| Dossier Risk | The CSDT file, ISO 13485 evidence, LOA or labeling package does not match submission expectations. |
| Language Risk | Bahasa Indonesia labeling or IFU is not aligned with the submitted data. |
| Renewal Risk | The LOA or holder arrangement does not support a full-term NIE or clean renewal path. |
Costs & Fees
Indonesia medical device registration costs arise from several separate components rather than one single filing step. Company-license readiness, dossier complexity, local holder model, translation and renewal planning can all affect the cost profile.
| Company-License Costs | IDAK preparation, CDAKB audit readiness and maintaining the licensed holder create foundational cost before product filing. |
| Assessment Costs | Classification analysis, holder strategy and Indonesia route planning can be substantial depending on device complexity and commercial model. |
| Dossier Costs | Preparing the CSDT file, ISO evidence, risk analysis, authorization materials and supporting reports can generate meaningful direct and indirect cost. |
| Submission Costs | Portal handling, government fees and application-management work add practical operational cost. |
| Localization Costs | Bahasa translation and label alignment can add material cost. |
| Maintenance Costs | Renewal, holder changes and continuing compliance obligations create ongoing expense after launch. |
FAQ
The FAQ section addresses recurring threshold questions in Indonesia market-entry work.
| Who Regulates Medical Devices in Indonesia? | Medical devices in Indonesia are regulated by the Ministry of Health through its medical-device licensing framework and Regalkes platform. |
| What Is Regalkes? | The Regalkes portal states that it is the online registration application used to facilitate licensing processes that issue Izin Edar product permits. |
| What Is the Difference Between IDAK and NIE? | Indonesia registration guidance explains that IDAK licenses the company to distribute medical devices, while NIE is the product-level marketing authorization for one specific device. |
| Can a Foreign Manufacturer Hold the NIE Directly? | No. Indonesia registration guidance explains that a foreign manufacturer cannot hold the Indonesian NIE directly. |
| Is CDAKB Important for Product Filing? | Yes. Indonesia registration guidance explains that the holder must already have IDAK and CDAKB before a product can be registered. |
| How Long Can the NIE Run? | Indonesia registration guidance explains that the NIE runs for up to five years and is renewable. |
Practical Guidance
Practical guidance helps a business prepare before finalising an Indonesia market-entry strategy.
| Checklist | Is the product a medical device under Indonesian rules? What risk class applies? Which Indonesian legal entity will hold the registration? Does the holder already have IDAK and CDAKB? Is the LOA term aligned with the intended market-authorisation period? Is the ASEAN CSDT dossier complete? Are Bahasa labels and IFUs aligned with the submission? Is the commercial model exposed to distributor lock-in because of who holds the NIE? Are renewal and change-control responsibilities clearly allocated? |
A disciplined Indonesia registration review should start with holder architecture as well as the product file. In many failed launches, the visible filing problem is only a later symptom of an earlier error about who controls the NIE, whether IDAK and CDAKB were truly ready or whether the authorization term supported the intended commercial model.
Jurisdictional Expert
The Jurisdictional Expert section records the status of the registry position associated with this jurisdictional object. It remains separate from the editorial content.
| Registry Position ID | RE-ID-MDR-001 |
| Registry Position | Jurisdictional Expert Medical Device Registration Indonesia |
| Registry Availability | Open |
| Verification Status | No verified participant currently assigned to this registry position. |
| Coverage | Indonesia medical device registration with emphasis on Ministry of Health oversight, Regalkes, IDAK, CDAKB, local license-holder logic, NIE issuance, CSDT dossier structure and commercial-control issues around holder choice. |
| Registry Reference | MAR-ID-MDR-001-A Jurisdictional Expert Position |
| Contact Information | Registry position not yet assigned. |
Machine Layer
This section contains machine-oriented registry fields retained for indexing, retrieval, system organisation and future rendering control. It may be visually minimised while remaining fully available in the HTML source.
| Object DNA | medical device registration indonesia ministry of health regalkes idak cdakb nie akl akd csdt class a class b class c class d local license holder market access |
| AI Retrieval Summary | Neutral registry object describing how medical device registration operates in Indonesia, including Ministry of Health oversight, Regalkes filing, IDAK and CDAKB company readiness, local holder requirements and NIE product authorization. |
| Entity Index | Indonesia Medical Device Registration Ministry of Health Regalkes IDAK CDAKB NIE AKL AKD CSDT Class A Class B Class C Class D |
| Machine Metadata | Registry rendering layer https://market-access-records.org/css/registry.css | Object ID ID.MDR.001 | Machine Reference MAR-ID-MDR-001-A | Internal Classification Business > Regulatory & Market Access > Medical Device Registration > Indonesia | Checksum 0xMDR40ID |
| Internal References | Registry Object | Jurisdiction Node | Editorial Record | Jurisdictional Expert Position | Machine-readable Reference Node |